These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2153549

  • 1. A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene.
    Fujita H, Suzuki H, Kuzumaki N, Müllauer L, Ogiso Y, Oda A, Ebisawa K, Sakurai T, Nonomura Y, Kijimoto-Ochiai S.
    Exp Cell Res; 1990 Jan; 186(1):115-21. PubMed ID: 2153549
    [Abstract] [Full Text] [Related]

  • 2. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H.
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [Abstract] [Full Text] [Related]

  • 3. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L.
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [Abstract] [Full Text] [Related]

  • 4. Elevated gelsolin and alpha-actin expression in a flat revertant R1 of Ha-ras oncogene-transformed NIH/3T3 cells.
    Müllauer L, Fujita H, Suzuki H, Katabami M, Hitomi Y, Ogiso Y, Kuzumaki N.
    Biochem Biophys Res Commun; 1990 Sep 14; 171(2):852-9. PubMed ID: 2169737
    [Abstract] [Full Text] [Related]

  • 5. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L, Fujita H, Ishizaki A, Kuzumaki N.
    Oncogene; 1993 Sep 14; 8(9):2531-6. PubMed ID: 8395682
    [Abstract] [Full Text] [Related]

  • 6. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
    Yamada H, Omata-Yamada T, Lengyel P.
    J Biol Chem; 1991 Feb 25; 266(6):4002-9. PubMed ID: 1995648
    [Abstract] [Full Text] [Related]

  • 7. Reduced induction of c-fos but not of c-myc expressions in a nontumorigenic revertant R1 of Ej-ras-transformed NIH/3T3 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Suzuki H, Fujita H, Ogiso Y, Oda A, Kuzumaki N, Uchino J.
    Exp Cell Res; 1989 Oct 25; 184(2):524-8. PubMed ID: 2509225
    [Abstract] [Full Text] [Related]

  • 8. Functions of [His321]gelsolin isolated from a flat revertant of ras-transformed cells.
    Fujita H, Laham LE, Janmey PA, Kwiatkowski DJ, Stossel TP, Banno Y, Nozawa Y, Müllauer L, Ishizaki A, Kuzumaki N.
    Eur J Biochem; 1995 May 01; 229(3):615-20. PubMed ID: 7758454
    [Abstract] [Full Text] [Related]

  • 9. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
    Oda A.
    Hokkaido Igaku Zasshi; 1988 Sep 01; 63(5):747-53. PubMed ID: 3071519
    [Abstract] [Full Text] [Related]

  • 10. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N, Ogiso Y, Oda A, Fujita H, Suzuki H, Sato C, Müllauer L.
    Mol Cell Biol; 1989 May 01; 9(5):2258-63. PubMed ID: 2664473
    [Abstract] [Full Text] [Related]

  • 11. Identification of genes that exhibit increased expression after flat reversion of NIH/3T3 cells transformed by human activated Ha-ras oncogene.
    Müllauer L, Suzuki H, Fujita H, Katabami M, Kuzumaki N.
    Cancer Lett; 1991 Jul 26; 59(1):37-43. PubMed ID: 1878859
    [Abstract] [Full Text] [Related]

  • 12. EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase.
    Heldman AW, Kandzari DE, Tucker RW, Crawford LE, Fearon ER, Koblan KS, Goldschmidt-Clermont PJ.
    Circ Res; 1996 Feb 26; 78(2):312-21. PubMed ID: 8575075
    [Abstract] [Full Text] [Related]

  • 13. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO, Kraynak AR, Storer RD, Gibbs JB.
    Proc Natl Acad Sci U S A; 1986 Jul 26; 83(14):5277-81. PubMed ID: 3523488
    [Abstract] [Full Text] [Related]

  • 14. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y.
    Hokkaido Igaku Zasshi; 1988 Sep 26; 63(5):687-97. PubMed ID: 3071518
    [Abstract] [Full Text] [Related]

  • 15. p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells.
    Higgins PJ, Ryan MP.
    Biochem J; 1991 Nov 01; 279 ( Pt 3)(Pt 3):883-90. PubMed ID: 1953684
    [Abstract] [Full Text] [Related]

  • 16. Growth-inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts.
    Ishizaki A, Fujita H, Kuzumaki N.
    Exp Cell Res; 1995 Apr 01; 217(2):448-52. PubMed ID: 7698245
    [Abstract] [Full Text] [Related]

  • 17. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
    Omata-Yamada T, Yamada H, Lengyel P.
    J Cell Physiol; 1991 Nov 01; 149(2):214-21. PubMed ID: 1748716
    [Abstract] [Full Text] [Related]

  • 18. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS, Zwiebel JA, Noda M, Bassin RH.
    J Cell Physiol; 1984 Oct 01; 121(1):22-30. PubMed ID: 6090475
    [Abstract] [Full Text] [Related]

  • 19. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB, Merrill GA, Brenner FJ, Lytle LS, Lam T, McElhinney A, Anders J, Rock TT, Lyker JK, Barcus S, Leslie KH, Kramer JM, Rubenstein EM, Pryor Schanz K, Parkhurst AJ, Peck M, Good K, Granath KL, Cifra N, Detweiler JW, Stevens L, Albertson R, Deir R, Stewart E, Wingard K, Richardson MR, Blizard SB, Gillespie LE, Kriley CE, Rzewnicki DI, Jones DH.
    Exp Cell Res; 2016 Jan 01; 340(1):1-11. PubMed ID: 26254261
    [Abstract] [Full Text] [Related]

  • 20. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
    Chang MY, Won SJ, Liu HS.
    J Cancer Res Clin Oncol; 1997 Jan 01; 123(2):91-9. PubMed ID: 9030247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.